Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Martignoni

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2001
Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosisF Bonetti, G Martignoni, C Colato, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2009
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomasG Martignoni, M Pea, S Gobbo, et al.
Tumori|February 24, 2001
The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trialS Mosconi, S Cascinu, A Zaniboni, et al.
Cancer Treatment Reviews|January 15, 2015
PD-1 blockade therapy in renal cell carcinoma: current studies and future promisesF Massari, M Santoni, C Ciccarese, et al.
Tissue Antigens|October 1, 1996
Expression of MHC class I and class II antigens in pancreatic adenocarcinomasM T Scupoli, S Sartoris, G Tosi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancerS Cascinu, R R Silva, R Labianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract CancerS Cascinu, R Labianca, P Alessandroni, et al.
The Journal of Pathology|April 1, 1997
bcl-2 expression in pleural and extrapleural solitary fibrous tumoursM Chilosi, F Facchettti, A P Dei Tos, et al.
British Journal of Cancer|April 15, 2004
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, M Scartozzi, R Labianca, et al.
Histology and Histopathology|December 13, 2012
Review of renal carcinoid tumor with focus on clinical and pathobiological aspectsN Kuroda, A Tanaka, C Ohe, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2001
Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosisF Bonetti, G Martignoni, C Colato, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2009
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomasG Martignoni, M Pea, S Gobbo, et al.
Tumori|February 24, 2001
The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trialS Mosconi, S Cascinu, A Zaniboni, et al.
Cancer Treatment Reviews|January 15, 2015
PD-1 blockade therapy in renal cell carcinoma: current studies and future promisesF Massari, M Santoni, C Ciccarese, et al.
Tissue Antigens|October 1, 1996
Expression of MHC class I and class II antigens in pancreatic adenocarcinomasM T Scupoli, S Sartoris, G Tosi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancerS Cascinu, R R Silva, R Labianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract CancerS Cascinu, R Labianca, P Alessandroni, et al.
The Journal of Pathology|April 1, 1997
bcl-2 expression in pleural and extrapleural solitary fibrous tumoursM Chilosi, F Facchettti, A P Dei Tos, et al.
British Journal of Cancer|April 15, 2004
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, M Scartozzi, R Labianca, et al.
Histology and Histopathology|December 13, 2012
Review of renal carcinoid tumor with focus on clinical and pathobiological aspectsN Kuroda, A Tanaka, C Ohe, et al.
Pageof 8